What are the major opportunities in the Liver Cancer Diagnostics market? What are the strategies for the Liver Cancer Diagnostics market?

For detailed insights on the major opportunities and strategies in the Liver Cancer Diagnostics market, Read More

How does the Liver Cancer Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Liver Cancer Diagnostics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Liver Cancer Diagnostics market growth? SWOT analysis of the Liver Cancer Diagnostics market.

For detailed insights on the key dynamics influencing the Liver Cancer Diagnostics market growth and SWOT analysis of the Liver Cancer Diagnostics industry, Read More

Liver Cancer Diagnostics Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Liver Cancer Diagnostics Market Report 2026

Name: Liver Cancer Diagnostics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma), By Screening (Laboratory Testing, Imaging, Biopsy, Other Screenings), By Technology (Fluorescent In Situ Hybridization (FISH), Immunohistochemical (IHC), Other Technologies), By End Use (Hospitals And Diagnostic Laboratories, Academic And Research Institutes) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Liver Cancer Diagnostics Market Overview

• Liver Cancer Diagnostics market size has reached to $10.32 billion in 2025

• Expected to grow to $14.75 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%

• Growth Driver: Surge In Liver Cancer Cases Fueling The Growth Of The Market Due To Rising Prevalence And Mortality Rates

• Market Trend: Advanced Biomarker-Based Assays Launched To Improve Liver Cancer Diagnostics

• North America was the largest region in 2025.

What Is Covered Under Liver Cancer Diagnostics Market?

Liver cancer diagnostics refers to the various methods employed to detect and diagnose liver cancer, a type of cancer that originates in the liver. It is used for the early detection and diagnosis of liver cancer via imaging and molecular testing.

The main types of cancer included in liver cancer diagnostics are hepatocellular carcinoma, cholangiocarcinoma, hepatoblastoma, and others. Hepatocellular carcinoma (HCC) refers to the primary liver cancer that most commonly affects people who have cirrhosis and preexisting chronic liver disease. The several types of screening are involved are laboratory testing, imaging, endoscopy, biopsy, and others. The various types of technology are included, such as fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), immunohistochemical (IHC), and others, which are used in several end uses, such as hospitals and diagnostic laboratories, academic and research institutes, and pharmaceutical and CRO laboratories.

Liver Cancer Diagnostics market report bar graph

What Is The Liver Cancer Diagnostics Market Size and Share 2026?

The liver cancer diagnostics market size has grown strongly in recent years. It will grow from $10.32 billion in 2025 to $11.07 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing prevalence of chronic liver diseases, rising incidence of hepatocellular carcinoma, expansion of hospital diagnostic infrastructure, growing awareness of early cancer screening, advancements in imaging and pathology techniques.

What Is The Liver Cancer Diagnostics Market Growth Forecast?

The liver cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $14.75 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing adoption of precision oncology diagnostics, rising demand for non-invasive diagnostic methods, expansion of molecular testing capabilities, growing investments in oncology research, increasing use of ai-assisted diagnostic platforms. Major trends in the forecast period include increasing adoption of advanced molecular diagnostic tests, rising use of imaging-based early detection tools, growing integration of biomarker-based screening methods, expansion of personalized oncology diagnostics, enhanced focus on early-stage cancer detection.

Book your 30 minutes free consultation with our research experts

Global Liver Cancer Diagnostics Market Segmentation

1) By Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma

2) By Screening: Laboratory Testing, Imaging, Biopsy, Other Screenings

3) By Technology: Fluorescent In Situ Hybridization (FISH), Immunohistochemical (IHC), Other Technologies

4) By End Use: Hospitals And Diagnostic Laboratories, Academic And Research Institutes

Subsegments:

1) By Hepatocellular Carcinoma: Early-Stage Hepatocellular Carcinoma, Advanced-Stage Hepatocellular Carcinoma

2) By Cholangiocarcinoma: Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma

3) By Hepatoblastoma: Pure Hepatoblastoma, Mixed Hepatoblastoma

What Is The Driver Of The Liver Cancer Diagnostics Market?

The rising prevalence of liver cancer is expected to propel the growth of the liver cancer diagnostics market going forward. Liver cancer refers to a condition in which the liver cells grow and multiply out of control, giving rise to a life-threatening illness. Liver cancer diagnostic tests are performed to determine whether cancer cells are spreading within the liver or surrounding it after the diagnosis of primary carcinoma of the liver, so the rising prevalence of liver cancer boosts the liver cancer diagnostics market. For instance, in January 2023, according to the Cancer Facts & Figures 2023 report published by the American Cancer Society, a US-based voluntary health organization, the number of new cases of liver and intrahepatic bile duct cancer in US females reached 13,230 in 2023. Furthermore, in 2023, an estimated 41,210 new cases of liver cancer were diagnosed in the US, where 29,380 people are expected to die. Therefore, the rising prevalence of liver cancer is driving the growth of the liver cancer diagnostic industry.

Key Players In The Global Liver Cancer Diagnostics Market

Major companies operating in the liver cancer diagnostics market are Abbott Laboratories, F Hoffmann La Roche Ltd, Qiagen NV, Thermo Fisher Scientific Inc, Siemens Healthineers, Illumina Inc, Koninklijke Philips NV, Epigenomics AG, Digna Biotech SL, Biocept Inc, Danaher Corporation, Foundation Medicine Inc, Agilent Technologies Inc, Genemed Biotechnologies Inc, Merck KGaA, Fujifilm Medical Systems USA Inc, GE Healthcare, Advanced Cell Diagnostics Inc, Oxford Gene Technology, Leica Biosystems Nussloch GmbH, Exiqon AS, BioGenex Laboratories Inc, OncoCyte Corporation, Guardant Health Inc, Exact Sciences Corporation, Grail Inc, Freenome Holdings Inc, Natera Inc, Personal Genome Diagnostics Inc, Thrive Earlier Detection Corp

Global Liver Cancer Diagnostics Market Trends and Insights

Major companies operating in the liver cancer diagnostics market are developing advanced biomarker-based assays and algorithms to improve diagnostic accuracy and support early detection. Biomarker-based assays and algorithms refer to diagnostic tools that utilize specific biological markers to identify diseases, providing more precise and efficient diagnostic capabilities. For instance, in November 2023, Roche Diagnostics, a US-based biotech corporation, launched the Elecsys PIVKA-II assay and Elecsys GAAD algorithm. The Elecsys PIVKA-II assay detects elevated levels of the PIVKA-II biomarker, which is associated with hepatocellular carcinoma (HCC), improving early detection of liver cancer in high-risk patients. The Elecsys GAAD algorithm integrates multiple diagnostic markers, such as PIVKA-II and AFP, to enhance diagnostic precision and streamline decision-making in liver cancer detection.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Liver Cancer Diagnostics Market?

In December 2024, Metropolis Healthcare Ltd., an India-based healthcare diagnostics company, acquired Core Diagnostics for $0.0278 billion. With this acquisition, Metropolis aims to significantly enhance its advanced cancer-testing capabilities and expand its presence in north and east India, strengthening its leadership in the specialized diagnostics space. CORE Diagnostics Private Limited is a India-based specialty diagnostics company that provide provides tests for liver cancer diagnostics.

Regional Outlook

North America was the largest region in the liver cancer diagnostics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Liver Cancer Diagnostics Market?

The liver cancer diagnostics market includes revenues earned by entities by liver transplants, CT scans, and liver function tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver cancer diagnostics market also includes sales of In Vitro and Imaging Tools, AI tools, and ML tools which are used in providing liver cancer diagnostic services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Liver Cancer Diagnostics Market Report 2026?

The liver cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the liver cancer diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Liver Cancer Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$11.07 billion
Revenue Forecast In 2035	$14.75 billion
Growth Rate	CAGR of 7.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Screening, Technology, End Use
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Abbott Laboratories, F Hoffmann La Roche Ltd, Qiagen NV, Thermo Fisher Scientific Inc, Siemens Healthineers, Illumina Inc, Koninklijke Philips NV, Epigenomics AG, Digna Biotech SL, Biocept Inc, Danaher Corporation, Foundation Medicine Inc, Agilent Technologies Inc, Genemed Biotechnologies Inc, Merck KGaA, Fujifilm Medical Systems USA Inc, GE Healthcare, Advanced Cell Diagnostics Inc, Oxford Gene Technology, Leica Biosystems Nussloch GmbH, Exiqon AS, BioGenex Laboratories Inc, OncoCyte Corporation, Guardant Health Inc, Exact Sciences Corporation, Grail Inc, Freenome Holdings Inc, Natera Inc, Personal Genome Diagnostics Inc, Thrive Earlier Detection Corp
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Liver Cancer Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Liver Cancer Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Liver Cancer Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Liver Cancer Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Advanced Molecular Diagnostic Tests

4.2.2 Rising Use Of Imaging-Based Early Detection Tools

4.2.3 Growing Integration Of Biomarker-Based Screening Methods

4.2.4 Expansion Of Personalized Oncology Diagnostics

4.2.5 Enhanced Focus On Early-Stage Cancer Detection

5. Liver Cancer Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Laboratories

5.3 Academic And Research Institutes

5.4 Pharmaceutical Companies

5.5 Contract Research Organizations

6. Liver Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Liver Cancer Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Liver Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Liver Cancer Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Liver Cancer Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Liver Cancer Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Liver Cancer Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Liver Cancer Diagnostics Market Segmentation

9.1. Global Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma

9.2. Global Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Laboratory Testing, Imaging, Biopsy, Other Screenings

9.3. Global Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fluorescent In Situ Hybridization (FISH), Immunohistochemical (IHC), Other Technologies

9.4. Global Liver Cancer Diagnostics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Diagnostic Laboratories, Academic And Research Institutes

9.5. Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatocellular Carcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early-Stage Hepatocellular Carcinoma, Advanced-Stage Hepatocellular Carcinoma

9.6. Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Cholangiocarcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma

9.7. Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatoblastoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pure Hepatoblastoma, Mixed Hepatoblastoma

10. Liver Cancer Diagnostics Market Regional And Country Analysis

10.1. Global Liver Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Liver Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Liver Cancer Diagnostics Market

11.1. Asia-Pacific Liver Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Liver Cancer Diagnostics Market

12.1. China Liver Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Liver Cancer Diagnostics Market

13.1. India Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Liver Cancer Diagnostics Market

14.1. Japan Liver Cancer Diagnostics Market Overview

14.2. Japan Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Liver Cancer Diagnostics Market

15.1. Australia Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Liver Cancer Diagnostics Market

16.1. Indonesia Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Liver Cancer Diagnostics Market

17.1. South Korea Liver Cancer Diagnostics Market Overview

17.2. South Korea Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Liver Cancer Diagnostics Market

18.1. Taiwan Liver Cancer Diagnostics Market Overview

18.2. Taiwan Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Liver Cancer Diagnostics Market

19.1. South East Asia Liver Cancer Diagnostics Market Overview

19.2. South East Asia Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Liver Cancer Diagnostics Market

20.1. Western Europe Liver Cancer Diagnostics Market Overview

20.2. Western Europe Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Liver Cancer Diagnostics Market

21.1. UK Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Liver Cancer Diagnostics Market

22.1. Germany Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Liver Cancer Diagnostics Market

23.1. France Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Liver Cancer Diagnostics Market

24.1. Italy Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Liver Cancer Diagnostics Market

25.1. Spain Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Liver Cancer Diagnostics Market

26.1. Eastern Europe Liver Cancer Diagnostics Market Overview

26.2. Eastern Europe Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Liver Cancer Diagnostics Market

27.1. Russia Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Liver Cancer Diagnostics Market

28.1. North America Liver Cancer Diagnostics Market Overview

28.2. North America Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Liver Cancer Diagnostics Market

29.1. USA Liver Cancer Diagnostics Market Overview

29.2. USA Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Liver Cancer Diagnostics Market

30.1. Canada Liver Cancer Diagnostics Market Overview

30.2. Canada Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Liver Cancer Diagnostics Market

31.1. South America Liver Cancer Diagnostics Market Overview

31.2. South America Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Liver Cancer Diagnostics Market

32.1. Brazil Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Liver Cancer Diagnostics Market

33.1. Middle East Liver Cancer Diagnostics Market Overview

33.2. Middle East Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Liver Cancer Diagnostics Market

34.1. Africa Liver Cancer Diagnostics Market Overview

34.2. Africa Liver Cancer Diagnostics Market, Segmentation By Type, Segmentation By Screening, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Liver Cancer Diagnostics Market Regulatory and Investment Landscape

36. Liver Cancer Diagnostics Market Competitive Landscape And Company Profiles

36.1. Liver Cancer Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Liver Cancer Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Liver Cancer Diagnostics Market Company Profiles

36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F Hoffmann La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Qiagen NV Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

37. Liver Cancer Diagnostics Market Other Major And Innovative Companies

Illumina Inc, Koninklijke Philips NV, Epigenomics AG, Digna Biotech SL, Biocept Inc, Danaher Corporation, Foundation Medicine Inc, Agilent Technologies Inc, Genemed Biotechnologies Inc, Merck KGaA, Fujifilm Medical Systems USA Inc, GE Healthcare, Advanced Cell Diagnostics Inc, Oxford Gene Technology, Leica Biosystems Nussloch GmbH

38. Global Liver Cancer Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Liver Cancer Diagnostics Market

40. Liver Cancer Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Liver Cancer Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Liver Cancer Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Liver Cancer Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Liver Cancer Diagnostics Market, Overview Of Key Products - Product Examples

Table 2: Global Liver Cancer Diagnostics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Liver Cancer Diagnostics Market, Supply Chain Analysis

Table 4: Global Liver Cancer Diagnostics Market, Major Raw Material Providers

Table 5: Global Liver Cancer Diagnostics Market, Major Resource Providers

Table 6: Global Liver Cancer Diagnostics Market, Major Manufacturers (Suppliers)

Table 7: Global Liver Cancer Diagnostics Market, Major Distributors And Channel Partners

Table 8: Global Liver Cancer Diagnostics Market, Key Technologies & Future Trends

Table 9: Global Liver Cancer Diagnostics Market, Major Trends

Table 10: Global Liver Cancer Diagnostics Market, Major End Users

Table 11: Global Liver Cancer Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Liver Cancer Diagnostics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Liver Cancer Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Liver Cancer Diagnostics Market - TAM, US$ Billion, 2025

Table 15: Global Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Liver Cancer Diagnostics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatocellular Carcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Cholangiocarcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatoblastoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Liver Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Liver Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Liver Cancer Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Liver Cancer Diagnostics Market - Company Scoring Matrix

Table 98: Abbott Laboratories Financial Performance

Table 99: F Hoffmann La Roche Ltd Financial Performance

Table 100: Qiagen NV Financial Performance

Table 101: Thermo Fisher Scientific Inc Financial Performance

Table 102: Siemens Healthineers Financial Performance

Table 103: Global Liver Cancer Diagnostics Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Liver Cancer Diagnostics Market, Competitive Dashboard

Table 105: Global Liver Cancer Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Liver Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Liver Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Screening, 2025 – 2030

Table 108: Global, Liver Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

List Of Figures

Figure 1: Global Liver Cancer Diagnostics Market, Overview Of Key Products - Product Examples

Figure 2: Global Liver Cancer Diagnostics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Liver Cancer Diagnostics Market, Supply Chain Analysis

Figure 4: Global Liver Cancer Diagnostics Market, Major Raw Material Providers

Figure 5: Global Liver Cancer Diagnostics Market, Major Resource Providers

Figure 6: Global Liver Cancer Diagnostics Market, Major Manufacturers (Suppliers)

Figure 7: Global Liver Cancer Diagnostics Market, Major Distributors And Channel Partners

Figure 8: Global Liver Cancer Diagnostics Market, Key Technologies & Future Trends

Figure 9: Global Liver Cancer Diagnostics Market, Major Trends

Figure 10: Global Liver Cancer Diagnostics Market, Major End Users

Figure 11: Global Liver Cancer Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Liver Cancer Diagnostics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Liver Cancer Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Liver Cancer Diagnostics Market - TAM, US$ Billion, 2025

Figure 15: Global Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Liver Cancer Diagnostics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatocellular Carcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Cholangiocarcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatoblastoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Liver Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Liver Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Liver Cancer Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Liver Cancer Diagnostics Market - Company Scoring Matrix

Figure 98: Abbott Laboratories Financial Performance

Figure 99: F Hoffmann La Roche Ltd Financial Performance

Figure 100: Qiagen NV Financial Performance

Figure 101: Thermo Fisher Scientific Inc Financial Performance

Figure 102: Siemens Healthineers Financial Performance

Figure 103: Global Liver Cancer Diagnostics Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Liver Cancer Diagnostics Market, Competitive Dashboard

Figure 105: Global Liver Cancer Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Liver Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Liver Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Screening, 2025 – 2030

Figure 108: Global, Liver Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

2025 Analysis: Opportunities and Risks in the Evolving Healthcare Chromatography Analyzers Market

Future Projections: Healthcare Smart Card Reader Market to Reach $3.12 Billion by 2029 at 17.8% CAGR

Industry Forecast: Hemostatic Agents Market to Generate $5.43 Billion Revenue by 2029

CAGR of 6.6% Projected for Hemostats And Tissue Sealants Market From 2025 to 2029

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Explore strategic insights and forecasts in the global virtual biopsy market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Global Nuclear Reactor Market.

Liver Health Supplements Market Report 2026 - Global Outlook – By Product (Vitamin And Minerals, Herbal Supplements, Other Products), By Nature (Organic, Conventional), By Form (Dry, Tablets, Powder, Liquid), By Distribu...

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Unresectable Hepatocellular Carcinoma Market Report 2026 - Global Outlook – By Type (Primary, Secondary, Benign Liver Growth), By Treatment Type (Chemotherapy, Molecularly Targeted Therapy, Immunotherapy, Other Treatment...

Liver Diseases Therapeutics Market Report 2026 - Global Outlook – By Disease Type (Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer ), By Treatment (Antiviral, Chemotherapy, Immunosuppressive A...

Liver Metastases Treatment Market Report 2026 - Global Outlook – By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy), By Primary Cancer (Colorectal Cancer, Breast Cancer), By Distribution Channel (Hospital ...

Hepatitis Diagnostic Tests Market Report 2026 - Global Outlook – By Test Type (Blood Tests, Imaging Tests, Liver Biopsy), By Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDTs), Polymeras...

Pancreatic Cancer Diagnostic Market Report 2026 - Global Outlook – By Product (Instruments, Consumables, Services), By Treatment (Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy), By Cancer Type (Exocrine, Ade...

Frequently Asked Questions

How big is the Liver Cancer Diagnostics Market?

The Liver Cancer Diagnostics market was valued at $10.32 billion in 2025, increased to $11.07 billion in 2026, and is projected to reach $14.75 billion by 2030. request a sample here

What is the Liver Cancer Diagnostics market growth?

The global Liver Cancer Diagnostics market is expected to grow at a CAGR of 7.4% from 2026 to 2035 to reach $14.75 billion by 2035. request a sample here

Who are the key players in Liver Cancer Diagnostics market?

Some Key Players in the Liver Cancer Diagnostics market Include, Abbott Laboratories, F Hoffmann La Roche Ltd, Qiagen NV, Thermo Fisher Scientific Inc, Siemens Healthineers, Illumina Inc, Koninklijke Philips NV, Epigenomics AG, Digna Biotech SL, Biocept Inc, Danaher Corporation, Foundation Medicine Inc, Agilent Technologies Inc, Genemed Biotechnologies Inc, Merck KGaA, Fujifilm Medical Systems USA Inc, GE Healthcare, Advanced Cell Diagnostics Inc, Oxford Gene Technology, Leica Biosystems Nussloch GmbH, Exiqon AS, BioGenex Laboratories Inc, OncoCyte Corporation, Guardant Health Inc, Exact Sciences Corporation, Grail Inc, Freenome Holdings Inc, Natera Inc, Personal Genome Diagnostics Inc, Thrive Earlier Detection Corp . request a sample here

What is the anticipated growth trend for the Liver Cancer Diagnostics market?

Major trend in this market includes: Advanced Biomarker-Based Assays Launched To Improve Liver Cancer Diagnostics. For further insights on this market. request a sample here

Which region has the most growth potential in the Liver Cancer Diagnostics market?

North America was the largest region in the liver cancer diagnostics market in 2025. The regions covered in the liver cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Liver Cancer Diagnostics Market Report 2026 market?

Major companies operating in the Liver Cancer Diagnostics Market Report 2026 market are Major companies operating in the liver cancer diagnostics market are Abbott Laboratories, F Hoffmann La Roche Ltd, Qiagen NV, Thermo Fisher Scientific Inc, Siemens Healthineers, Illumina Inc, Koninklijke Philips NV, Epigenomics AG, Digna Biotech SL, Biocept Inc, Danaher Corporation, Foundation Medicine Inc, Agilent Technologies Inc, Genemed Biotechnologies Inc, Merck KGaA, Fujifilm Medical Systems USA Inc, GE Healthcare, Advanced Cell Diagnostics Inc, Oxford Gene Technology, Leica Biosystems Nussloch GmbH, Exiqon AS, BioGenex Laboratories Inc, OncoCyte Corporation, Guardant Health Inc, Exact Sciences Corporation, Grail Inc, Freenome Holdings Inc, Natera Inc, Personal Genome Diagnostics Inc, Thrive Earlier Detection Corp request a sample here.

Which region has the most growth potential in the Liver Cancer Diagnostics Market Report 2026 market?